| Net profit of Procter & Gamble Health rose 54.63% to Rs 94.60 crore in the quarter ended March 2026 as against Rs 61.18 crore during the previous quarter ended March 2025. Sales rose 19.12% to Rs 370.45 crore in the quarter ended March 2026 as against Rs 310.99 crore during the previous quarter ended March 2025.
For the full year,net profit rose 39.46% to Rs 326.91 crore in the year ended March 2026 as against Rs 234.41 crore during the previous year ended March 2025. Sales rose 50.72% to Rs 1407.97 crore in the year ended March 2026 as against Rs 934.17 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | | Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. |
| Sales | 370.45 | 310.99 | 19 | 1407.97 | 934.17 | 51 |
| OPM % | 36.60 | 26.02 | - | 32.43 | 34.08 | - |
| PBDT | 139.38 | 83.90 | 66 | 473.45 | 328.31 | 44 |
| PBT | 133.21 | 78.53 | 70 | 449.86 | 311.62 | 44 |
| NP | 94.60 | 61.18 | 55 | 326.91 | 234.41 | 39 |
|